Unraveling the Aquaporin-3 Inhibitory Effect of Rottlerin by Experimental and Computational Approaches
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms24066004 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Inês Paccetti-Alves und 4 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal. Hauptthemen laut MEDLINE: Aquaporin 3, Aquaporins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, FCT-Fundação para a Ciência e Tecnologia, Portugal, European Union.
Abstract (Originalsprache)
The natural polyphenolic compound Rottlerin (RoT) showed anticancer properties in a variety of human cancers through the inhibition of several target molecules implicated in tumorigenesis, revealing its potential as an anticancer agent. Aquaporins (AQPs) are found overexpressed in different types of cancers and have recently emerged as promising pharmacological targets. Increasing evidence suggests that the water/glycerol channel aquaporin-3 (AQP3) plays a key role in cancer and metastasis. Here, we report the ability of RoT to inhibit human AQP3 activity with an IC50 in the micromolar range (22.8 ± 5.82 µM for water and 6.7 ± 2.97 µM for glycerol permeability inhibition). Moreover, we have used molecular docking and molecular dynamics simulations to understand the structural determinants of RoT that explain its ability to inhibit AQP3. Our results show that RoT blocks AQP3-glycerol permeation by establishing strong and stable interactions at the extracellular region of AQP3 pores interacting with residues essential for glycerol permeation. Altogether, our multidisciplinary approach unveiled RoT as an anticancer drug against tumors where AQP3 is highly expressed providing new information to aquaporin research that may boost future drug design.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Research Institute for Medicines (iMed.ULisboa), Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.
- Department of Pharmaceutical Sciences and Medicines, Faculty of Pharmacy, Universidade de Lisboa, 1649-003 Lisbon, Portugal.
- Biosystems and Integrative Sciences Institute, Faculty of Sciences, Universidade de Lisboa, 1649-003 Lisbon, Portugal.
ORCID-Profile: Inês Paccetti-Alves, Marta S P Batista, Catarina Pimpão, Bruno L Victor, Graça Soveral
Förderung
- Fundação para a Ciência e Tecnologia
- FCT-Fundação para a Ciência e Tecnologia, Portugal
- European Union
Zitieren
APA
Paccetti-Alves, I., Batista, M. S. P., Pimpão, C., Victor, B. L., & Soveral, G. (2023). Unraveling the Aquaporin-3 Inhibitory Effect of Rottlerin by Experimental and Computational Approaches. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24066004
Vancouver
Paccetti-Alves I, Batista MSP, Pimpão C, Victor BL, Soveral G. Unraveling the Aquaporin-3 Inhibitory Effect of Rottlerin by Experimental and Computational Approaches. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24066004
BibTeX
@article{PaccettiAlves2023,
author = {Paccetti-Alves, Inês and Batista, Marta S P and Pimpão, Catarina and Victor, Bruno L and Soveral, Graça},
title = {Unraveling the Aquaporin-3 Inhibitory Effect of Rottlerin by Experimental and Computational Approaches},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms24066004}
}
EUVIMED